Chargement en cours...
A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosis
BACKGROUND: Antiepidermal growth factor receptor (EGFR)-targeted therapy is widely used in many epithelial cancer types. We investigated lapatinib effects on cutaneous squamous cell carcinoma (cSCC) scheduled for resection and in coexisting precursor lesions (actinic keratosis (AK) and Bowen's...
Enregistré dans:
| Publié dans: | ESMO Open |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070204/ https://ncbi.nlm.nih.gov/pubmed/27843579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2015-000003 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|